As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

The French medical charity Doctors Without Borders/Médecins Sans Frontières said Wednesday that at least two patients at its ...

The WebMD Group uses AI to help in the creation ... A dedicated PharmD staff compiles Medscape’s proprietary drug monographs and drug interactions, based primarily on US drug approvals and ...

Chamlin will spearhead the development and implementation of commercial strategies for Aspargo's groundbreaking oral spray ...

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

If you’re having difficulty maintaining pregnancy, your doctor may check for some known causes of miscarriage, as per a WebMd ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...